Deoxycholic Acid and Lithocholic Acid Alleviate Liver Injury and Inflammation in Mice with Klebsiella pneumoniae-Induced Liver Abscess and Bacteremia

References

• Lin YT, Liu CJ, Fung CP, Tzeng CH. Nosocomial Klebsiella pneumoniae bacteraemia in adult cancer patients–characteristics of neutropenic and non-neutropenic patients. Scand J Infect Dis. 2011;43(8):603–608. doi:10.3109/00365548.2011.577800
   PubMed Web of Science ®Google Scholar
• Lin YT, Chen TL, Siu LK, Hsu SF, Fung CP. Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis. 2010;29(8):1003–1010. doi:10.1007/s10096-010-0961-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother. 2016;60(10):6115–6120. doi:10.1128/aac.01127-16
   PubMed Web of Science ®Google Scholar
• Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008;14(10):1592–1600. doi:10.3201/eid1410.071254
   PubMed Web of Science ®Google Scholar
• Shon AS, Russo TA. Hypervirulent Klebsiella pneumoniae: the next superbug? Future Microbiol. 2012;7(6):669–671. doi:10.2217/fmb.12.43
   PubMed Web of Science ®Google Scholar
• Lin YT, Siu LK, Lin JC, et al. Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC Microbiol. 2012;12(1):13. doi:10.1186/1471-2180-12-13
   PubMedGoogle Scholar
• Yeh KM, Kurup A, Siu LK, et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol. 2007;45(2):466–471. doi:10.1128/jcm.01150-06
   PubMed Web of Science ®Google Scholar
• Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect. 2007;54(6):578–583. doi:10.1016/j.jinf.2006.11.008
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park KS, et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017;7:483. doi:10.3389/fcimb.2017.00483
   PubMed Web of Science ®Google Scholar
• Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014;7(1):17–44. doi:10.3390/nu7010017
   PubMed Web of Science ®Google Scholar
• Duan Y, Llorente C, Lang S, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505–511. doi:10.1038/s41586-019-1742-x
   PubMed Web of Science ®Google Scholar
• Mouries J, Brescia P, Silvestri A, et al. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71(6):1216–1228. doi:10.1016/j.jhep.2019.08.005
   PubMed Web of Science ®Google Scholar
• Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64. doi:10.1038/nature13568
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940–947. doi:10.1016/j.jhep.2013.12.019
   PubMed Web of Science ®Google Scholar
• Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012;16(5):559–564. doi:10.1016/j.cmet.2012.10.007
   PubMed Web of Science ®Google Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–669. doi:10.1016/j.cmet.2013.03.013
   PubMed Web of Science ®Google Scholar
• Devlin AS, Fischbach MA. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol. 2015;11(9):685–690. doi:10.1038/nchembio.1864
   PubMed Web of Science ®Google Scholar
• Stellwag EJ, Hylemon PB. 7Alpha-dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res. 1979;20(3):325–333. doi:10.1016/S0022-2275(20)40615-7
   PubMed Web of Science ®Google Scholar
• Stellwag EJ, Hylemon PB. Characterization of 7-alpha-dehydroxylase in Clostridium leptum. Am J Clin Nutr. 1978;31(10Suppl):S243–s247. doi:10.1093/ajcn/31.10.S243
   PubMedGoogle Scholar
• Stadler J, Stern HS, Yeung KS, et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids. Gut. 1988;29(10):1326–1331. doi:10.1136/gut.29.10.1326
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, van Mil SW, Oldenburg B, Siersema PD, Klomp LW, van Erpecum KJ. Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta. 2010;1801(7):683–692. doi:10.1016/j.bbalip.2010.04.006
   PubMed Web of Science ®Google Scholar
• Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15(27):3329–3340. doi:10.3748/wjg.15.3329
   PubMed Web of Science ®Google Scholar
• Ward JBJ, Lajczak NK, Kelly OB, et al. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol. 2017;312(6):G550–g558. doi:10.1152/ajpgi.00256.2016
   PubMed Web of Science ®Google Scholar
• Winkler ES, Shrihari S, Hykes BL Jr. The intestinal microbiome restricts alphavirus infection and dissemination through a bile acid-type I IFN signaling axis. Cell. 2020;182(4):901–918.e918. doi:10.1016/j.cell.2020.06.029
   Web of Science ®Google Scholar
• Sinha SR, Haileselassie Y, Nguyen LP, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(4):659–670.e655. doi:10.1016/j.chom.2020.01.021
   PubMed Web of Science ®Google Scholar
• Lenz AM, Fairweather M, Peyton JC, Gardner SA, Cheadle WG. Liver injury and abscess formation in secondary murine peritonitis. Inflamm Res. 2011;60(4):337–345. doi:10.1007/s00011-010-0273-6
   PubMed Web of Science ®Google Scholar
• La Frano MR, Hernandez-Carretero A, Weber N, et al. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid-sensitive gene expression in insulin target tissues of C57BL/6J mice. Nutr Res. 2017;46:11–21. doi:10.1016/j.nutres.2017.07.006
   PubMed Web of Science ®Google Scholar
• Wu T, Xu F, Su C, et al. Alterations in the gut microbiome and cecal metabolome during klebsiella pneumoniae-induced pneumosepsis. Front Immunol. 2020;11:1331. doi:10.3389/fimmu.2020.01331
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–352. doi:10.1038/nri.2016.42
   PubMed Web of Science ®Google Scholar
• Ling Z, Liu X, Jia X. Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children. Sci Rep. 2014;4(1):7485. doi:10.1038/srep07485
   PubMedGoogle Scholar
• Ling Z, Liu X, Cheng Y. Decreased diversity of the oral microbiota of patients with hepatitis b virus-induced chronic liver disease: a pilot project. Sci Rep. 2015;5(1):17098. doi:10.1038/srep17098
   PubMedGoogle Scholar
• Lin YT, Tseng KY, Yeh YC, Yang FC, Fung CP, Chen NJ. TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice. Infect Immun. 2014;82(3):1335–1342. doi:10.1128/iai.01347-13
   PubMed Web of Science ®Google Scholar
• Lin YT, Liu CJ, Yeh YC, Chen TJ, Fung CP. Ampicillin and amoxicillin use and the risk of Klebsiella pneumoniae liver abscess in Taiwan. J Infect Dis. 2013;208(2):211–217. doi:10.1093/infdis/jit157
   PubMed Web of Science ®Google Scholar
• Fei J, Fu L, Hu B, et al. Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice. Int Immunopharmacol. 2019;66:177–184. doi:10.1016/j.intimp.2018.11.005
   PubMed Web of Science ®Google Scholar
• Peermohamed S, Kogilwaimath S. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae causing pyogenic liver abscess. Cmaj. 2018;190(14):E441. doi:10.1503/cmaj.171344
   PubMed Web of Science ®Google Scholar
• Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi:10.1038/nbt.2942
   PubMed Web of Science ®Google Scholar
• Huttenhower C, Gevers D, Knight R, et al.. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi:10.1038/nature11234
   PubMed Web of Science ®Google Scholar
• Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12(4):851–861. doi:10.1038/s41385-019-0162-4
   PubMed Web of Science ®Google Scholar
• Biesalski HK. Nutrition meets the microbiome: micronutrients and the microbiota. Ann N Y Acad Sci. 2016;1372(1):53–64. doi:10.1111/nyas.13145
   PubMed Web of Science ®Google Scholar
• Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019;7(1):91. doi:10.1186/s40168-019-0704-8
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Biagioli M, Zampella A, Distrutti E. Bile acids activated receptors regulate innate immunity. Front Immunol. 2018;9:1853. doi:10.3389/fimmu.2018.01853
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee YK, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A. 2006;103(10):3920–3925. doi:10.1073/pnas.0509592103
   PubMed Web of Science ®Google Scholar
• Hoh CH, Tan YH, Gan YH, Torres VJ. Protective role of kupffer cells and macrophages in Klebsiella pneumoniae -induced liver abscess disease. Infect Immun. 2019;87(9). doi:10.1128/iai.00369-19
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431(7007):461–466. doi:10.1038/nature02924
   PubMed Web of Science ®Google Scholar
• D’Acquisto F, Ianaro A. From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors. Curr Opin Pharmacol. 2006;6(4):387–392. doi:10.1016/j.coph.2006.02.009
   PubMed Web of Science ®Google Scholar
• Cipriani S, Mencarelli A, Chini MG, et al. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One. 2011;6(10):e25637. doi:10.1371/journal.pone.0025637
   PubMed Web of Science ®Google Scholar
• Keitel V, Donner M, Winandy S, Kubitz R, Häussinger D. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun. 2008;372(1):78–84. doi:10.1016/j.bbrc.2008.04.171
   PubMed Web of Science ®Google Scholar
• Voss OH, Murakami Y, Pena MY, et al. Lipopolysaccharide-induced CD300b receptor binding to toll-like receptor 4 alters signaling to drive cytokine responses that enhance septic shock. Immunity. 2016;44(6):1365–1378. doi:10.1016/j.immuni.2016.05.005
   PubMed Web of Science ®Google Scholar